<DOC>
	<DOC>NCT02718352</DOC>
	<brief_summary>Many buprenorphine treatment programs do not have services dedicated to adolescents and young adults. As a precursor to developing and evaluating an adolescent and young adult buprenorphine treatment program at APT Foundation Inc, we propose to conduct a 1 year prospective study of 16 to 25 year old treatment-seeking individuals enrolled in the APT Adolescent and Young Adult Suboxone Program</brief_summary>
	<brief_title>A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence</brief_title>
	<detailed_description>Participants will consent to in-person assessments and monthly chart reviews. We anticipate that the results from this study will inform the development of future services targeted towards adolescents and young adults with opioid dependence.</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<criteria>Ages 16 through 25 at time of induction Meet criteria for enrollment in the APT Adolescent and Young Adult Suboxone Program (Opioid Dependence per DSMV criteria; no contraindications to buprenorphine (concomitant benzodiazepine, alcohol use, sedative use), Stable enough to participate in outpatient care/intensive outpatient care for at least 12 weeks; Can commit to at least 12 weeks of treatment through the APT Adolescent and Young Adult Suboxone Program Are willing to provide locator information for followup. Are fluent in English and have a 6th grader or higher reading level Have an untreated bipolar or schizophrenic disorder, or active suicidal ideation Are physically dependent on alcohol, benzodiazepines, or other sedatives. Are in custody of the Department of Children and Families</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>